Industry News
Gene editing therapy paves way for revolution in treatment of genetic disorders
It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis
It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis
UCL academics are working with Causaly to help accelerate research into the COVID-19 pandemic, including the identification of biomarkers and potential therapeutic agents